Prabhakar Baliga to Biopsy
This is a "connection" page, showing publications Prabhakar Baliga has written about Biopsy.
Connection Strength
0.170
-
Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant. Am J Transplant. 2019 01; 19(1):98-109.
Score: 0.034
-
Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients. Pediatr Transplant. 2016 Feb; 20(1):44-8.
Score: 0.028
-
Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Pediatr Transplant. 2015 Aug; 19(5):555-62.
Score: 0.027
-
Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014 May; 259(5):888-93.
Score: 0.026
-
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011 Dec; 17(12):1394-403.
Score: 0.022
-
Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? Transplantation. 2005 Dec 15; 80(11):1633-5.
Score: 0.014
-
Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation. Am J Transplant. 2003 Oct; 3(10):1278-88.
Score: 0.012
-
Biochemical and histopathological correlation in liver transplant: the first 180 days. Hepatology. 1992 Sep; 16(3):688-93.
Score: 0.006